Collaborative Initial Glaucoma Treatment Study: a summary of results to date

Area of Science:

• Ophthalmology
• Glaucoma Research
• Clinical Trials

Background:

• Open-angle glaucoma (OAG) is a leading cause of irreversible blindness.
• Determining the optimal initial treatment strategy for OAG is crucial for preserving vision.
• The Collaborative Initial Glaucoma Treatment Study (CIGTS) was established to compare medical therapy and surgical intervention.

Purpose of the Study:

• To evaluate the efficacy of medical therapy versus trabeculectomy as initial treatments for open-angle glaucoma.
• To assess the impact of these treatments on visual field progression, intraocular pressure, visual acuity, and quality of life.

Main Methods:

• A randomized clinical trial comparing medical management with trabeculectomy in patients with OAG.
• Long-term follow-up to monitor visual field changes, intraocular pressure, visual acuity, and patient-reported quality of life outcomes.

Main Results:

• No significant difference in visual field loss was observed between the medical and surgical groups over 4+ years.
• Trabeculectomy resulted in lower intraocular pressures but increased risks of visual acuity loss and cataract progression.
• Quality of life was similar, though surgical patients reported more local eye symptoms.

Conclusions:

• The CIGTS findings do not support a change in current clinical practices for the initial management of primary open-angle glaucoma.
• The study provides valuable data for informed decision-making in glaucoma treatment selection.